Hemorrhage risk associated with triple antithrombotic therapy: a focused real-world pharmacovigilance disproportional analysis study
Crossref DOI link: https://doi.org/10.1186/s12872-025-04510-4
Published Online: 2025-03-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sridharan, Kannan https://orcid.org/0000-0003-3811-6503
Sivaramakrishnan, Gowri
Text and Data Mining valid from 2025-03-14
Version of Record valid from 2025-03-14
Article History
Received: 5 December 2024
Accepted: 20 January 2025
First Online: 14 March 2025
Declarations
:
: The authors declare no competing interests.